MetLife Investment Management’s iCAD Inc ICAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,918
Closed -$154K 2577
2021
Q2
$154K Hold
8,918
﹤0.01% 2312
2021
Q1
$189K Sell
8,918
-774
-8% -$13K ﹤0.01% 2088
2020
Q4
$128K Sell
9,692
-557
-5% -$6.01K ﹤0.01% 2190
2020
Q3
$90.3K Sell
10,249
-134
-1% -$1.32K ﹤0.01% 2230
2020
Q2
$104K Buy
+10,383
New +$112K ﹤0.01% 2240

Other funds holding ICAD

MetLife Investment Management's ICAD Position: Q3 2021 in Review

MetLife Investment Management sold out of iCAD Inc (ICAD) in Q3 2021, closing a stake of 8,918 shares — an estimated $154K sold.

MetLife Investment Management first reported a position in ICAD in Q2 2020 and held it in 5 quarters. The position peaked at $189K in Q1 2021. 80 funds tracked by Wall St. Rank hold ICAD as of Q3 2021.

  • MetLife Investment Management reported no remaining iCAD Inc position as of Q3 2021 after selling out during the quarter.
  • MetLife Investment Management sold 8,918 iCAD Inc shares in Q3 2021, an estimated $154K.
  • MetLife Investment Management first reported a position in iCAD Inc in Q2 2020 and held it in 5 quarters.
  • MetLife Investment Management's iCAD Inc position peaked at $189K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held iCAD Inc as of Q3 2021.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.